Literature DB >> 1176093

Studies on polypeptides, VI. Synthesis, circular dichroism and immunological studies of tyrosyl C-peptide of human proinsulin.

V K Naithani, M Dechesne, J Markussen, L G Heding, U D Larsen.   

Abstract

The synthesis of tyrosyl human C-peptide, a sequence of 32 amino acids, by the fragment condensation of the N-terminal octapeptide and C-terminal tetracosapeptide is described. The t-butyl protecting groups were removed by trifluoroacetic acid to obtain N-benzyloxycarbonyl-tyrosyl C-peptide. The hydrogenolytic debenzyl-oxycarbonylation of this derivative proceeded to an extent of only 80-90%, and tyrosyl C-peptide was purified by preparative electrophoresis. This purified tyrosyl C-peptide led to an improved sensitivity of the radioimmunoassay. The synthetic tyrosyl C-peptide in an immunoassay using anti human b-component serum reacted slightly differently from the synthetic human C-peptide. After labelling tyrosyl C-peptide with 125I and then purifying the radioactive product, we observed that 80% of the radioactivity could be bound when reacted with an excess of the serum. The circular dichroism spectrum of tyrosyl C-peptide is very similar to that of synthetic human C-peptide. An analysis of the spectrum indicates that 3-7 amino acids are in the beta-structure and the rest in random coil conformation.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1176093     DOI: 10.1515/bchm2.1975.356.2.1305

Source DB:  PubMed          Journal:  Hoppe Seylers Z Physiol Chem        ISSN: 0018-4888


  3 in total

1.  Specific and direct radioimmunoassay for human proinsulin in serum.

Authors:  L G Heding
Journal:  Diabetologia       Date:  1977-09       Impact factor: 10.122

2.  Radioimmunological determination of human C-peptide in serum.

Authors:  L G Heding
Journal:  Diabetologia       Date:  1975-12       Impact factor: 10.122

Review 3.  History and diagnostic significance of C-peptide.

Authors:  Dietrich Brandenburg
Journal:  Exp Diabetes Res       Date:  2008
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.